Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
Kidney International Reports|November 17, 2017
Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate HydrateKeitaro Yokoyama, Masafumi Fukagawa, Takashi Akiba, et al.
Clinical Transplantation|July 21, 2015
Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysisAditya Kadiyala, Anna T Mathew, Mala Sachdeva, et al.
American Journal of Nephrology|July 31, 2020
COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case SeriesMala Sachdeva, Nupur N Uppal, Jamie S Hirsch, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 2, 2008
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney diseaseDennis L Andress, Daniel W Coyne, Kamyar Kalantar-Zadeh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2008
History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patientsSteven M Brunelli, Marshall M Joffe, Rubeen K Israni, et al.
Kidney International|August 19, 2020
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Jia H Ng, Jamie S Hirsch, Rimda Wanchoo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patientsJeffrey S Berns, Steven Fishbane, Hafez Elzein, et al.
Kidney International Reports|May 5, 2018
Potentially Avoidable Readmissions in United States Hemodialysis PatientsAnna T Mathew, Lisa Rosen, Renee Pekmezaris, et al.
International Journal of Nephrology and Renovascular Disease|April 18, 2022
Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary CohortJessica B Kendrick, Meijiao Zhou, Linda H Ficociello, et al.
Pageof 24